Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for Basal Joint Arthritis Treatments

Official title: Prospective Study on Basal Joint Arthritis of the Thumb

Run by Columbia University · NCT01376024 · Data updated 2026-11-12

This study is collecting information to see which treatments work best for people with thumb arthritis, helping to find the most effective ways to relieve pain and improve function.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment800 (estimated)
SponsorColumbia University
Academic / other
Locations3 sites (Rochester, Minnesota and 2 other locations)
StatusRecruiting
StartedMarch 2, 2007
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedJune 10, 2026
Trial IDNCT01376024 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with symptomatic basal joint arthritis who can provide informed consent.

Probably not a fit

Patients with inflammatory arthritic conditions or those unable to comply with study guidelines may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to collect data on the effectiveness of various surgical and non-operative techniques for treating basal joint arthritis of the thumb. By analyzing patient-specific characteristics and treatment outcomes, the study seeks to identify the most effective and cost-efficient methods for pain relief and functional restoration. The findings will also help shape future randomized controlled trials focused on optimal treatment strategies for this condition. No interventions will be made to patient care during the study.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies and better patient outcomes for those suffering from basal joint arthritis.

How similar studies have gone: While there have been few multi-center prospective trials on this topic, the study builds on existing meta-analyses and aims to fill gaps in current knowledge.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have symptomatic basal joint arthritis.
* Patients who are capable of providing informed consent.

Exclusion Criteria:

* Patients younger than 18 years old at the time of enrollment.
* Patients with neuromuscular disease affecting the operated hand, not caused by the CMC operation.
* Patients with known inflammatory arthritic conditions, such as rheumatoid or psoriatic arthritis.
* Patients with a history of or current infection of the basal joint of the affected hand.
* Patients who are demented or are unable to provide informed consent.
* Patients unable to comply with study guidelines.
* Patients who have metacarpophalangeal joint hyperextension are NOT excluded. These patients will be followed and if they receive a capsulodesis or other procedure at the MCPJ at the same time as their basal joint arthroplasty this will be noted in their data records.

Where it's running

  • Columbia University/NY Presbyterian Hospital
    New York, New York, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Terminated
  • Vanderbilt University Hospital
    Nashville, Tennessee, United States
    Terminated

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.